During January and February, Wolverhampton Clinical Commissioning Group (CCG) is asking children and young people, aged 11 – 25, “What matters to you about your healthcare?”

Staff from the CCG will be visiting local colleges, universities and other venues to speak to children and young people to get their views.

To take part in this survey click here. If you would like the survey forwarded to you in an alternative format, please contact WOLCCG.comms@nhs.net

Wolverhampton CCG is undertaking Phase 3 of the Harmonised Clinical Treatment Policy Project. This harmonised approach across Wolverhampton is to facilitate consistent, evidence based policy development for planned patient care.

The remit of the Harmonised Treatment Policy Project is outlined by the Lead Planned Care GP Dr Geoff Naylor:

‘Treatment policies are designed to provide fair, consistent, and transparent access to treatment for patients. CCGs have finite resources and are required to ensure treatment policies are evidence-based, achieve best clinical outcomes for patients and provide the most cost-effective use of NHS resources. Our treatment policies have been developed to be informed by the most up to date clinical evidence, best practice and clinical opinion nationally. During this engagement period in Phase 3 treatment policies we would really value and appreciate feedback from clinical colleagues to ensure our next phase of treatment policies are as clinically robust as possible for our local patients.’

Between Thursday 5 September and Friday 11 October, Wolverhampton CCG will be engaging with clinical colleagues and the public regarding Phase 3a which includes the following 3 DRAFT policies:

1. Subacromial Pain
2. Image guided therapeutic intra-articular joint injections with corticosteroids with/without local anaesthetic.
3. Image-guided HIGH VOLUME intra-articular injections (40mls+) of saline with or without corticosteroid and/or local anaesthetic.

Continue Reading